SenzaGen
Lund, Swedensenzagen.comFrom their website, Nov 2026
- GLP
- ISO 9001
Work here? Claim this listing
About
SenzaGen develops and provides in vitro testing and advisory services for skin sensitization, medical devices, and regulatory toxicology. It serves companies in pharmaceuticals, medical devices, cosmetics, and chemicals from its headquarters in Lund, Sweden, with group companies in Sweden and additional specialized operations through VitroScreen, ToxHub, and Alcyomics.
Services
GARD skin sensitization testing
In vitro skin sensitization hazard assessment using GARD skin, including OECD 442E and OECD 497 defined approaches.
GARD skin quantitative potency assessment
Dose-response testing with GARD skin to provide quantitative potency information for skin sensitizers.
GARD air respiratory sensitization testing
In vitro hazard assessment for respiratory sensitization using GARD air.
Medical device biological evaluation
Support for biological evaluation of medical devices, including planning, testing, analysis, and documentation.
In vitro biocompatibility testing
In vitro testing for cytotoxicity, irritation, and skin sensitization for medical devices.
Regulatory toxicity testing
Standard in vitro toxicity testing for skin, eye, phototoxicity, and genotoxicity endpoints with regulatory guidance.
Advisory services for medical devices
Regulatory and toxicological advisory support for medical devices, including biological evaluation plans, reports, risk assessment, and classification support.
Medical device qualification
Assessment of whether a substance-based product qualifies as a medical device under the EU MDR based on mode of action evidence.
5 more services
- Medical device classification
- Regulatory toxicology advisory for pharmaceuticals
- GARD Sensitization Testing
- Medical Device Services
- Advisory Services
- Turnaround
- 2-4 weeks for standard studies
- What to send
- Test item extracts prepared in line with ISO 10993-12
- Medical device extracts and solid materials
- Neat chemicals
- Mixtures
- Extracts
- Formulations
Capabilities
- Assays and studies
- Toxicology
- Skin sensitization
- Respiratory sensitization
- Cytotoxicity
- Irritation
- Skin corrosion
11 more
- Skin absorption
- Eye irritation
- Phototoxicity
- Genotoxicity
- Biological evaluation
- Biocompatibility testing
- ADME profile
- Pharmacological appraisal
- Toxicological risk assessment
- In vitro biocompatibility testing
- Regulatory toxicity testing
- Therapeutic areas
- Dermatology
- Gastroenterology
- Gynaecology
- Ophthalmology
- Medical devices
- Pharma
- Chemicals
Instruments and platforms
- GARD technology
Modalities and species
- Modalities
- Small molecule
- Species and models
- L-929 cells
- Mouse fibroblast
- Human dendritic-like cell line SenzaCell
- Human skin explants
- 3D reconstructed human epidermis
- Full-thickness skin
3 more
- 3D human epithelial models
- Intestinal models
- Human cell-based 3D spheroids
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 9001Self-reported
Scope: VitroScreen quality system
ISO 13485Self-reported
Scope: VitroScreen quality system
GLPSelf-reported
Scope: SenzaGen and VitroScreen have fully GLP-certified lab operations
Industries served
- Pharma
- Medical devices
- Cosmetics
- Chemical
Details
- Type
- CRO
- Based in
- Lund, Sweden
- Serves
- Europe, United Kingdom, USA
- Phone
- +46 46 275 62 00
Public records
- Parent company
- SenzaGen AB · SE GLEIF